ArticleProceedings of the National Academy of Sciences of the United States of America2017

Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.

Masaki Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.